Why the study?
Updated evidence and new recommendations were needed to guide clinicians in the management of patients with lower extremity peripheral artery disease across multiple clinical presentations.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The 2024 ACC/AHA/Multisociety Guideline for the Management of Lower Extremity Peripheral Artery Disease (PAD) and the 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia collectively represent a major paradigm shift toward more aggressive, unified, and prevention-driven lipid-lo...”
This document provides updated 2024 multi-society clinical practice guidelines for the comprehensive management of lower extremity peripheral artery disease.
AIM: The "2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease" provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease across its multiple clinical presentation subsets (ie, asymptomatic, chronic symptomatic, chronic limb-threatening ischemia, and acute limb ischemia). METHODS: A comprehensive literature search was conducted from October 2020 to June 2022, encompassing studies, reviews, and other evidence conducted on human subjects that was published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through May 2023 during the peer review process, were also considered by the writing committee and added to the evidence tables where appropriate. STRUCTURE: Recommendations from the "2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease" have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with peripheral artery disease have been developed.
No takes yet. Share an insight, caveat, or question.
Gornik et al. (2024) conducted a review in Lower Extremity Peripheral Artery Disease. Management of Lower Extremity Peripheral Artery Disease was evaluated. The 2024 guideline provides updated evidence-based recommendations for the comprehensive care and management of patients with lower extremity peripheral artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: